Skip to content

Fenoterol

GENITO URINARY SYSTEM AND SEX HORMONES

Also known as: fenoterol HCl, fenoterol hydrobromide, fenoterol hydrochloride, phenoterol

YEAR INTRODUCED approvedATC G02CA03ATC R03AC04ATC R03AL01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Fenoterol is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1965. DrugCentral lists 4 molecular targets, including ADRB3, ADRB1 and Adrb2.

  • Molecular targets: ADRB3, ADRB1, Adrb2 and ADRB2 (4 listed in DrugCentral).
  • ATC code: G02CA03 (Sympathomimetics, labour repressants).
  • Molecular formula: C17H21NO4; molecular weight 303.36 g/mol.

Mechanism & targets

Molecular targets (4)

TargetGeneActionActivity
Beta-3 adrenergic receptorADRB3agonistEC50 7.60
Beta-1 adrenergic receptorADRB1agonistEC50 7.50
Beta-2 adrenergic receptorAdrb2unknownIC50 7.22
Beta-2 adrenergic receptorADRB2agonistEC50 6.90

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1965-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
G02CA03GENITO URINARY SYSTEM AND SEX HORMONES › OTHER GYNECOLOGICALS › OTHER GYNECOLOGICALS › Sympathomimetics, labour repressants
R03AC04RESPIRATORY SYSTEM › DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › ADRENERGICS, INHALANTS › Selective beta-2-adrenoreceptor agonists
R03AL01RESPIRATORY SYSTEM › DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › ADRENERGICS, INHALANTS › Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
R03CC04RESPIRATORY SYSTEM › DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › ADRENERGICS FOR SYSTEMIC USE › Selective beta-2-adrenoreceptor agonists

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Appendicolith238.2
Myasthenia gravis215.0
Blood phosphorus increased213.6
Hyperphosphataemia201.6
Appendicitis187.6
Blood uric acid increased168.8
Chronic obstructive pulmonary disease168.4
Ventricular fibrillation164.1
Hypophosphataemia146.4
Bacterial infection144.5
Cardiogenic shock140.1
Iron deficiency137.7

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Fenoterol is on its molecule page.

Molecular formulaC17H21NO4
Molecular weight303.36 g/mol
CAS number13392-18-2
InChIKeyLSLYOANBFKQKPT-UHFFFAOYSA-N
PubChem CID3343
CC(CC1=CC=C(O)C=C1)NCC(O)C1=CC(O)=CC(O)=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Fenoterol work?

Its molecular targets in DrugCentral include ADRB3 (agonist), ADRB1 (agonist), Adrb2 and ADRB2 (agonist).

When was Fenoterol first approved?

Fenoterol was first approved by the YEAR INTRODUCED in 1965.

What is the chemical formula of Fenoterol?

Fenoterol has the molecular formula C17H21NO4 and a molecular weight of 303.36 g/mol.

Browse: all drugs starting with F · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1965-01-01
AgencyYEAR INTRODUCED
Targets4
Indications0
FormulaC17H21NO4
DrugCentral ID1155
Interactive profile